Pass the Medical Council of Canada MCCQE Part 1 MCCQE Questions and answers with ExamsMirror

Comprehensive and Detailed Explanation:

Pulsatile tinnitus synchronous with the pulse may be vascular in origin. The association with headaches and elevated BMI (a risk factor for idiopathic intracranial hypertension, IIH) warrants neuroimaging to assess for cerebral venous sinus thrombosis, vascular malformations, or raised intracranial pressure.

Toronto Notes 2023 – Neurology / ENT:

“Pulsatile tinnitus requires investigation for vascular causes including idiopathic intracranial hypertension. MRI or MRV is the next step.”

MCCQE1 Objectives (Neurology > 35-1: Headache and Tinnitus):

“Candidates must investigate pulsatile tinnitus with neuroimaging when vascular causes are suspected.”

Audiogram (A) is for hearing loss. EEG (C) is not useful for tinnitus. CRP (D) is irrelevant.

====================================================

Given the request for opioids and history of non-prescribed opioid use (oxycodone obtained from a friend), the next appropriate step is to conduct a urine drug screen. This helps assess current substance use and guides safe prescribing decisions.

Toronto Notes 2023 – Pain Management and Addiction Medicine:

“Urine drug screening is recommended before initiating opioid therapy or when there is suspicion of substance misuse. A history of using non-prescribed opioids mandates assessment for opioid use disorder and further risk stratification.”

MCCQE1 Objectives – Internal Medicine > Chronic Pain:

“Candidates must assess for opioid misuse and dependence before initiating opioid therapy. Urine drug testing is a standard tool in this assessment.”

Providing naloxone (A) may be appropriate later if opioids are prescribed, but the priority is evaluation. Cannabis (B) is not first-line and lacks controlled evidence in chronic pain. Tramadol (D) is an opioid-like agent and not appropriate until misuse risk is evaluated.

This child presents with bilateral red, itchy, watery eyes for 2 weeks without purulent discharge, pain, or visual changes—classic features of allergic conjunctivitis . MCCQE objectives emphasize distinguishing allergic conjunctivitis from infectious causes. Allergic conjunctivitis is characterized by pruritus (key symptom), tearing, conjunctival injection, and often a history of atopy or seasonal triggers. Vision remains normal, and there is no mucopurulent discharge (which would suggest bacterial infection) or vesicular lesions/dendritic ulcers (suggesting viral/herpetic causes).

Topical antihistamines (often combined with mast cell stabilizers) are first-line therapy and effectively reduce itching and redness by blocking histamine-mediated inflammation.

Topical antibiotics are unnecessary without bacterial features. Antivirals are reserved for suspected herpetic disease. Antifungals are rarely indicated in routine conjunctivitis. Topical glucocorticoids are not first-line and may cause adverse effects (e.g., increased intraocular pressure) and should only be used under ophthalmologic supervision.

Therefore, a topical antihistamine is the most appropriate initial treatment.

In any suspected occupational exposure, the first step is a detailed occupational history to assess the nature, intensity, and duration of the exposure. This determines whether surveillance or further testing is appropriate.

Toronto Notes 2023 – Respiratory Medicine, “Occupational Lung Diseases” Section:

“When a patient presents with concerns about exposure to occupational hazards such as asbestos, detailed history is essential. Ask about job tasks, duration of exposure, use of personal protective equipment, and prior workplace assessments.”

MCCQE1 Objectives (Population Health > 97-2: Environmental and Occupational Health):

“Candidates must be able to obtain a detailed environmental and occupational history and determine the risk of exposure before ordering investigations.”

Ordering a chest radiograph (B) or PFTs (E) without confirming meaningful exposure is premature. Referral to a specialist (D) and reassurance (A) come only after the exposure risk is assessed.

====================================================

The best next step is to ensure valid informed consent by discussing the risks, benefits, alternatives, and consequences of refusal of a blood transfusion. According to MCCQE objectives, informed consent requires that the patient be capable, receive sufficient relevant information, understand the information provided, and voluntarily agree to the intervention. Simply informing the patient that a transfusion will help her feel better is inadequate and does not meet the standard for informed decision-making.

Administering the transfusion without this discussion violates patient autonomy unless there is an immediate life-threatening emergency and the patient lacks capacity. Asking a colleague to repeat the recommendation does not fulfill the obligation. Withholding treatment for liability reasons is inappropriate. Prior consent documented in the chart does not replace consent for the current clinical situation.

Therefore, a thorough discussion of indications, expected benefits (improved oxygen delivery, symptom relief), potential risks (transfusion reactions, infection, fluid overload), and alternatives is ethically and legally required before proceeding.

This patient has been assessed as incapable of making the decision regarding dialysis. MCCQE ELOM objectives emphasize that when a patient lacks decision-making capacity, treatment decisions must be made by a legally authorized substitute decision-maker (SDM) according to provincial/territorial hierarchy. The appropriate next step is to determine whether a formal SDM has been appointed (e.g., power of attorney for personal care) or identify the legally ranked default SDM.

Although the wife may often be the default SDM, this depends on jurisdiction and whether a formal representative has been designated. It is inappropriate to automatically follow the son’s wishes, as he may not be the legal SDM. Nor should the physician impose their own recommendation without engaging the proper decision-making process. A large family meeting may be helpful later but does not replace identifying the legally authorized decision-maker.

Once identified, the SDM must make decisions based on the patient’s prior capable wishes or, if unknown, the patient’s best interests. Properly establishing the SDM ensures ethical and legal compliance in incapacity situations.

Comprehensive and Detailed Explanation:

An estimated fetal weight below the 5th percentile at 30 weeks is concerning for intrauterine growth restriction (IUGR). This warrants prompt evaluation of fetal well-being via biophysical profile and Doppler assessment. The patient should be referred for further fetal assessment immediately to rule out placental insufficiency or other complications.

Toronto Notes 2023 – Obstetrics, “Fetal Growth Restriction”:

“EFW < 10th percentile, especially < 5th, warrants further evaluation including Doppler studies and biophysical profile. Immediate assessment is warranted to determine fetal well-being.”

MCCQE1 Objectives (Obstetrics > 80-4: Antepartum Surveillance):

“Candidates must initiate urgent assessment in cases of abnormal fetal growth to reduce perinatal morbidity.”

Delaying care (B) is inappropriate. Reassurance (A) is unsafe. ASA (D) is preventative, not corrective. Doppler (E) is important but should be coordinated through obstetrical triage.

====================================================

The description is classic for metatarsus adductus. The most important clinical factor guiding management is whether the foot is flexible or rigid. Flexible deformities typically resolve spontaneously and do not require intervention.

Toronto Notes 2023 – Pediatrics, “Musculoskeletal Conditions”:

“Metatarsus adductus: inward deviation of the forefoot. Management depends on flexibility. Flexible cases are benign and resolve spontaneously; rigid forms may need casting.”

MCCQE1 Objectives (Pediatrics > 78-2: Musculoskeletal Disorders):

“Candidates must assess and differentiate between flexible and rigid deformities to guide treatment in foot abnormalities.”

Other findings (B–E) are either unrelated or not determinant in metatarsus adductus management.

—

This patient presents with fever, chills, anorexia, and right upper quadrant (RUQ) pain several weeks after hospitalization for sigmoid diverticulitis . A key complication of intra-abdominal infections such as diverticulitis is portal pylephlebitis with hepatic abscess formation , due to bacterial spread via the portal venous system. MCCQE objectives emphasize recognizing liver abscess as a delayed complication of intra-abdominal sepsis, particularly when new RUQ pain and fever develop after an initial abdominal infection.

The most appropriate initial imaging test to confirm this diagnosis is ultrasound of the abdomen , which can detect hepatic abscesses and guide further management. CT abdomen is also highly sensitive, but among the listed options, ultrasound is most appropriate.

Chest and abdominal radiographs are nonspecific. HIDA scan evaluates cystic duct obstruction in suspected acute cholecystitis, which is less likely given the recent diverticulitis and systemic features. ERCP is used for biliary obstruction or ascending cholangitis, typically associated with jaundice.

Thus, abdominal ultrasound is most likely to confirm a hepatic abscess.

A first-degree relative with colorectal cancer diagnosed before age 60 places this patient in an increased-risk screening category. For individuals with one first-degree relative diagnosed with colorectal cancer (or advanced adenoma) before age 60, recommended screening is colonoscopy starting at age 40, or 10 years earlier than the age at diagnosis in the affected relative—whichever comes first—then repeated at shorter intervals than average-risk screening (often every 5 years if results are normal, depending on local guidance and findings). Here, her father was diagnosed at 55, so “10 years earlier” would be age 45; however, the “whichever comes first” rule makes age 40 the correct start. Average-risk strategies such as FIT starting at 50 are not sufficient for this risk level. Flexible sigmoidoscopy alone is less appropriate because it does not evaluate the proximal colon and is not the preferred increased-risk test. Double-contrast barium enema is obsolete for screening, and CT colonography is not first-line in this context. MCCQE objectives emphasize tailoring screening to family-history risk and selecting the appropriate test and start age.